Fortress Biotech Inc. (FBIO)
Market Open
12 Jun, 13:49
NASDAQ (CM) NASDAQ (CM) Primary $
2. 79
+0.04
+1.2681%
$
92.02M Market Cap
- P/E Ratio
- Div Yield
12,851 Volume
-5.8 Eps
$ 2.76
Previous Close Investors:
Want to track FBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fortress Biotech Inc. (FBIO) Statistics
Valuation metrics
Market Cap 92.02M
Enterprise value -114.18M
Trailing P/E (ttm) 0.65
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 1.33
Price/Book (mrq) 0.52
Enterprise Value/Revenue -1.73
Enterprise Value/EBITDA 21.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 354.26K
Average volume (90 days) 394.17K
Price summary
52-Week low 1.7
52-Week high 4.53
Beta -
50-Day moving average 2.48
200-Day moving average 3.03
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 10 Oct 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 1.93%
Operating margin -0.84%
Operational effectiveness
Return on assets 0.36%
Return on equity 1.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.11
Total debt (mrq) -
Total Debt/Equity (mrq) 0.33
Current ratio (mrq) 2.86%
Book value per share (mrq) 6.42
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
